Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/28/2016 11/29/2016 11/30/2016 12/01/2016 12/02/2016 Date
56.51(c) 56.36(c) 56.44(c) 55.8(c) 55.96 Last
8 724 213 9 818 891 16 418 924 12 719 553 9 279 904 Volume
-0.82% -0.27% +0.14% -1.13% +0.29% Change
More quotes
Financials ($)
Sales 2016 19 329 M
EBIT 2016 5 338 M
Net income 2016 4 615 M
Debt 2016 160 M
Yield 2016 2,80%
Sales 2017 19 985 M
EBIT 2017 5 654 M
Net income 2017 4 674 M
Finance 2017 797 M
Yield 2017 2,92%
P/E ratio 2016 20,32
P/E ratio 2017 19,65
EV / Sales2016 4,83x
EV / Sales2017 4,63x
Capitalization 93 255 M
More Financials
Company
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
12/03 | 11:30pmPresentation
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
12/01 BRISTOL MYERS SQUIBB : Studies from Bristol-Myers Squibb Yield New Information a..
12/01 BRISTOL MYERS SQUIBB : Trademark Application for "NIVDIREC" Filed
12/01 BRISTOL MYERS SQUIBB : Trademark Application for "IMMVIVUR" Filed
12/01 BRISTOL MYERS SQUIBB : European Commission Approves Bristol-Myers Squibb's Opdiv..
12/01 BRISTOL MYERS SQUIBB : Studies Conducted at Bristol-Myers Squibb on Alcohols Rec..
12/01 BRISTOL MYERS SQUIBB : New Findings from Bristol-Myers Squibb Update Understandi..
12/01 BRISTOL MYERS SQUIBB : New Hepatitis C Virus Study Findings Reported from Bristo..
12/01 BRISTOL MYERS SQUIBB : Trademark Application for "AWAKEN" Filed
12/01 QuintilesIMS Forms New Collaboration with Bristol-Myers Squibb, Lilly, Merck ..
11/30 BRISTOL MYERS SQUIBB : to Take Part at the Citi 2016 Global Healthcare Conferenc..
More news
Sector news : Pharmaceuticals - NEC
12:36a Pharma execs weigh in on possible changes under Trump
12:24aDJJOHNSON & JOHNSON : Jury Orders Johnson & Johnson to Pay More Than $1 Billion in..
12/01DJValeant Deal Talks Collapse Over Price -- WSJ
12/01DJCSL : Eyes Biggest Undertaking Yet in Heart Therapy Trial
12/01 GLAXOSMITHKLINE : GSK biotech asthma drug wins UK approval after extra price cut
More sector news : Pharmaceuticals - NEC
4-Traders Strategies on BRISTOL-MYERS SQUIBB CO 
09/26Attractive price levels
More Strategies
News from SeekingAlpha
12/01 Heat Biologics' lead product candidate flunks mid-stage bladder cancer study;..
12/01 Vantage Point - Going Small To Hit It Big
12/01 3 Ways To Maximize The Returns Of My Dividend Portfolio
11/29 Merck Boosts Dividend 2% And Has Several Key Growth Drivers
11/28 How To Evaluate And Select Winning Convertible Preferred Stocks
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends BRISTOL-MYERS SQU...
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 61,8 $
Spread / Average Target 11%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Giovanni Caforio Chief Executive Officer & Director
Lamberto Andreotti Chairman
Charles A. Bancroft Chief Financial Officer & Executive Vice President
Francis M. Cuss Chief Scientific Officer & Executive VP
Paul von Autenried Chief Information Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
BRISTOL-MYERS SQUIBB C..-17.95%93 255
JOHNSON & JOHNSON8.43%303 013
PFIZER INC.-2.54%190 910
ROCHE HOLDING LTD.-17.98%189 262
NOVARTIS AG-19.07%177 818
MERCK & CO., INC.15.85%167 524
More Results